Related Experiment Video
Updated: Aug 1, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
[Refractory hypotension during anesthesia in a patient treated with angiotensin receptor blockers]
L M Vaquero Roncero1, R Julián González, C Muriel Villoria
1Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario, Salamanca. luismariovaquero@yahoo.es
Abstract:
A 66-year-old woman treated with valsartan, an angiotensin II receptor blocker, and diuretics was scheduled for surgery to remove a pelvic mass. Both drugs were withdrawn 24 hours before anesthetic induction. Combined general and epidural anesthesia was provided. When hypotension developed and was refractory to fluid replacement and phenylephrine administration, terlipressin, a vasopressin receptor antagonist, was infused and outcome was favorable. Anesthetized patients treated with angiotensin II receptor blockers to control hypertension may experience hypotensive events that are refractory to standard treatment but that respond to vasopressin receptor antagonists.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

